Comments
Loading...

Nirvana Life Sciences Analyst Ratings

NIRVDOTCGM
Logo brought to you by Benzinga Data

Nirvana Life Sciences Analyst Ratings and Price Targets | OTC:NIRVD | Benzinga

Nirvana Life Sciences Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Nirvana Life Sciences Corp from these most-recent analyst ratings.

Analyst Ratings for Nirvana Life Sciences

Buy NowGet Alert
No data available to display

FAQ

Q

What is the target price for Nirvana Life Sciences (NIRVD) stock?

A

There is no price target for Nirvana Life Sciences

Q

What is the most recent analyst rating for Nirvana Life Sciences (NIRVD)?

A

There is no analyst for Nirvana Life Sciences

Q

When was the last upgrade for Nirvana Life Sciences (NIRVD)?

A

There is no last upgrade for Nirvana Life Sciences

Q

When was the last downgrade for Nirvana Life Sciences (NIRVD)?

A

There is no last downgrade for Nirvana Life Sciences.

Q

When is the next analyst rating going to be posted or updated for Nirvana Life Sciences (NIRVD)?

A

There is no next analyst rating for Nirvana Life Sciences.

Q

Is the Analyst Rating Nirvana Life Sciences (NIRVD) correct?

A

There is no next analyst rating for Nirvana Life Sciences.

Browse analyst ratings and price targets on all stocks.